Mestranol
Enovid, Norethin 1/50m, Norinyl, Ortho-novum, Ovulen (mestranol) is a small molecule pharmaceutical. Mestranol was first approved as Ovulen on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ethynodiol diacetate
+
Mestranol
Mestranol
+
Norethindrone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NORINYL 1+50 21-DAY | Allergan | N-013625 DISCN | 1982-01-01 | 1 products |
NORINYL | Allergan | N-013625 DISCN | 1982-01-01 | 1 products |
NORINYL 1+50 28-DAY | Allergan | N-016659 DISCN | 1982-01-01 | 1 products, RLD |
NORINYL 1+80 21-DAY | G.D. Searle | N-016724 DISCN | 1982-01-01 | 1 products |
NORINYL 1+80 28-DAY | G.D. Searle | N-016725 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/50 28 | Johnson & Johnson | N-016709 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 10-21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/50 21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 2-21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/80 21 | Johnson & Johnson | N-016715 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/80 28 | Johnson & Johnson | N-016715 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | MESTRANOL |
INN | mestranol |
Description | Mestranol is a terminal acetylenic compound that is (17alpha)-17-ethynylestra-1(10),2,4-triene substituted by a methoxy group at position 3 and a hydroxy group at position 17. It has a role as a prodrug and a xenoestrogen. It is a 17beta-hydroxy steroid, a terminal acetylenic compound and an aromatic ether. It is functionally related to a 17beta-estradiol. |
Classification | Small molecule |
Drug class | estrogens |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C |
Identifiers
PDB | — |
CAS-ID | 72-33-3 |
RxCUI | 6782 |
ChEMBL ID | CHEMBL1201151 |
ChEBI ID | 6784 |
PubChem CID | 6291 |
DrugBank | DB01357 |
UNII ID | B2V233XGE7 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,012 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
24 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more